Evidence supporting the use of: Vitamin E (beta tocotrienol)
For the health condition: Radiation Sickness

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Beta tocotrienol, a member of the Vitamin E family, has been investigated for its radioprotective properties, particularly in the context of radiation sickness. Preclinical studies, primarily in animal models, have demonstrated that tocotrienols (including beta tocotrienol) can mitigate radiation-induced damage. They appear to act by scavenging free radicals, reducing oxidative stress, and modulating cellular signaling pathways involved in inflammation and apoptosis. Several studies, such as those published in peer-reviewed journals like Radiation Research and International Journal of Radiation Oncology, highlight that tocotrienols can increase survival rates and reduce tissue damage in irradiated animals.

However, most of this evidence is limited to preclinical animal studies or in vitro experiments. Human clinical trials are sparse, and there is currently no robust, high-quality evidence supporting the efficacy of beta tocotrienol in preventing or treating radiation sickness in humans. Despite this, the promising results from laboratory and animal studies have led some researchers to propose tocotrienols as potential adjuncts in radioprotection strategies. Regulatory bodies have not approved beta tocotrienol for this indication, and its use remains investigational.

In summary, there is scientific interest and some animal-based evidence supporting the use of beta tocotrienol for radiation sickness, but clinical validation in humans is lacking. Accordingly, the strength of evidence is rated as 2 out of 5.

More about Vitamin E (beta tocotrienol)
More about Radiation Sickness

Products containing Vitamin E (beta tocotrienol)

We currently have no products on Caring Sunshine that contain this ingredient.